The us food and drug administration (fda) has announced that japanese pharmaceutical company, eisai, has agreed to voluntarily recall its weight-loss drug belviq (lorcaserin) after a long-term safety study linked the medication to an increased risk of cancer extended use of belviq increased risk of cancers including: colorectal cancer pancreatic cancer lung cancer the fda ‘s announcement. Belviq replacement. The belviq recall was issued on the heels of a review of belviq clinical trial data, which found an increased occurrence of cancer in belviq users according to the clinical trial results, patients taking belviq or belviq xr as a weight loss aid may be more likely to develop pancreatic cancer, lung cancer, colorectal cancer or another type of.
belviq replacement
Belviq is a weight loss medication in the middle of impending class action lawsuits for the manufacturer’s negligence in warning the public of the risk for cancer from taking the drug eisai co is the manufacturer and the company has voluntarily initiated a recall of the product due to its risk. Related to belviq: phentaslim review (new 2020) - why we rate it as #1. closing remarks. belviq is a real weight loss medication with the scientific research to prove it. it might be expensive, but it is meant to be obtained on a prescription basis, meaning medical insurance can often assist with the cost.. The findings of a new study suggest many reported heart rhythm problems associated with transcather aortic valve replacement (tavr) surgery may have actually been present in patients before they under.
0 komentar:
Posting Komentar